Ganaxolone for the Treatment of CDKL5 Disorder and Other Neurological and Psychiatric Conditions: A Review of the Clinical Trials
Crossref DOI link: https://doi.org/10.1007/s11940-025-00851-9
Published Online: 2025-09-23
Published Print: 2025-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lai, Sammie
Nordli, Douglas R. III
Galan, Fernando N.
Text and Data Mining valid from 2025-09-23
Version of Record valid from 2025-09-23
Article History
Received: 6 July 2025
Accepted: 7 August 2025
First Online: 23 September 2025
Declarations
:
: The authors declare no competing interests.